{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:37:25Z","timestamp":1785559045315,"version":"3.56.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012484","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000}}],"reference-count":245,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012484.pub2","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T10:13:08Z","timestamp":1576577588000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Beta-blockers for suspected or diagnosed acute myocardial infarction"],"prefix":"10.1002","author":[{"given":"Sanam","family":"Safi","sequence":"first","affiliation":[{"name":"Department 7812, Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research; Blegdamsvej 9 Copenhagen Denmark 2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naqash J","family":"Sethi","sequence":"additional","affiliation":[{"name":"Department 7812, Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research; Blegdamsvej 9 Copenhagen Denmark 2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil Eik","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department 7812, Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research; Blegdamsvej 9 Copenhagen Denmark 2100"},{"name":"Cardiology Section; Department of Internal Medicine; Smedelundsgade 60 Holbaek Danmark Denmark 4300"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Feinberg","sequence":"additional","affiliation":[{"name":"Department 7812, Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research; Blegdamsvej 9 Copenhagen Denmark 2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Department 7812, Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research; Blegdamsvej 9 Copenhagen Denmark 2100"},{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus C","family":"Jakobsen","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"},{"name":"Holbaek Hospital; Department of Cardiology; Holbaek Denmark 4300"},{"name":"University of Southern Denmark; Department of Regional Health Research, the Faculty of Health Sciences; Holbaek Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"issue":"8148","key":"10.1002\/14651858.CD012484.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(79)92684-9","article-title":"Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results","volume":"2","author":"Andersen","year":"1979","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0954-6820.1984.tb12905.x","article-title":"Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Study design, patient characteristics and conduct of the study","volume":"680","author":"J\u00fcrgensen","year":"1984","journal-title":"Acta Medica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.0954-6820.1984.tb12906.x","article-title":"The effect of long-term intervention with alprenolol on mortality in definite or suspected myocardial infarction","volume":"680","author":"J\u00fcrgensen","year":"1984","journal-title":"Acta Medica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/oxfordjournals.eurheartj.a059589","article-title":"Electrophysiological effects of intravenous sotalol in acute myocardial infarction: a double-blind placebo-controlled study","volume":"11","author":"\u00c5str\u00f6m","year":"1990","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/oxfordjournals.eurheartj.a061997","article-title":"Haemodynamic effects of intravenous sotalol in acute myocardial infarction","volume":"7","author":"\u00c5str\u00f8m","year":"1986","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD012484.pub2-BIB0007|cit7","first-page":"367","article-title":"The effect of pindolol on the two years mortality after complicated myocardial infarction","volume":"4","author":"Australian and Swedish Pindolol Study Group","year":"1983","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/01.CIR.66.5.986","article-title":"Effects of acebutolol on myocardial infarct extension: a randomised electrocardiographic, enzymatic and angiographic study","volume":"66","author":"Azancot","year":"1982","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0002-8703(67)90020-8","article-title":"A controlled trial of propranolol in acute myocardial infarction","volume":"74","author":"Balcon","year":"1967","journal-title":"American Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0010|cit10","first-page":"127","article-title":"Clinical trial of propranolol in acute myocardial infarction","volume":"36","author":"Barber","year":"1967","journal-title":"Ulster Medical Journal"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0954-6820.1976.tb05884.x","article-title":"Practolol in acute myocardial infarction","volume":"587","author":"Barber","year":"1976","journal-title":"Acta Medica Scandinavica Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.CIR.96.1.183","article-title":"Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial","volume":"96","author":"Basu","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0013|cit13","first-page":"231","article-title":"Randomized control of sympathetic drive with continuous intravenous esmolol in patients with acute ST-segment elevation myocardial infarction: the BEtA-blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial","volume":"9","author":"Er","year":"2016","journal-title":"JACC: Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijcard.2015.04.177","article-title":"Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial","volume":"190","author":"Er","year":"2015","journal-title":"International Journal of Cardiology"},{"issue":"454","key":"10.1002\/14651858.CD012484.pub2-BIB0015|cit15","first-page":"135","article-title":"Alprenolol in acute myocardial infarction: double-blind trial","volume":"71","author":"Briant","year":"1970","journal-title":"New Zealand Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/hrt.34.3.252","article-title":"Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset","volume":"34","author":"Reynolds","year":"1972","journal-title":"British Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"8","key":"10.1002\/14651858.CD012484.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"e0199347","DOI":"10.1371\/journal.pone.0199347","article-title":"Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"13","author":"Watanabe","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0167-5273(01)00437-5","article-title":"CAPRICORN: a story of alpha allocation and beta-blockers in left ventricular dysfunction post-MI","volume":"78","author":"Coats","year":"2001","journal-title":"International Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1388-9842(00)00098-2","article-title":"Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction","volume":"2","author":"Dargie","year":"2000","journal-title":"European Journal of Heart Failure"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1388-9842(02)00099-5","article-title":"The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?","volume":"4","author":"Otterstad","year":"2002","journal-title":"European Journal of Heart Failure"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00392-011-0360-x","article-title":"A low pulse pressure predicts mortality in subjects with heart failure after an acute myocardial infarction: a post-hoc analysis of the CAPRICORN study","volume":"101","author":"Petrie","year":"2012","journal-title":"Clinical Research in Cardiology"},{"issue":"9266","key":"10.1002\/14651858.CD012484.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"The CAPRICORN Investigators","year":"2001","journal-title":"Lancet"},{"issue":"7470","key":"10.1002\/14651858.CD012484.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0140-6736(66)90533-2","article-title":"Absence of prophylactic effect of propranolol in myocardial infarction","volume":"2","author":"Clausen","year":"1966","journal-title":"Lancet"},{"issue":"9497","key":"10.1002\/14651858.CD012484.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD012484.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/204748730000700608","article-title":"Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction","volume":"7","author":"Second Chinese Cardiac Study (CCS-2) Collaborative Group","year":"2000","journal-title":"Journal of Cardiovascular Risk"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/oxfordjournals.eurheartj.a061223","article-title":"An early intervention secondary prevention study with oxprenolol following myocardial infarction","volume":"2","author":"Coronary Prevention Research Group","year":"1981","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0028|cit28","first-page":"677","article-title":"Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction","volume":"51","author":"Daga","year":"2003","journal-title":"Journal of the Association of Physicians of India"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"152S","DOI":"10.1378\/chest.124.4_MeetingAbstracts.152S","article-title":"Effect of esmolol, an ultra-short acting beta blocker on oxidant status and antioxidant activity in acute myocardial infarction: Results of a randomized double-blind, controlled, prospective clinical study","volume":"124","author":"Sharma","year":"2003","journal-title":"Chest"},{"issue":"23","key":"10.1002\/14651858.CD012484.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.jacc.2016.03.522","article-title":"Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention","volume":"67","author":"Roolvink","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4244\/EIJ-D-17-00776","article-title":"One-year clinical outcome of early administration of intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary reperfusion","volume":"14","author":"Roolvink","year":"2018","journal-title":"EuroIntervention"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ahj.2014.07.015","article-title":"Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous beta-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY beta-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial","volume":"168","author":"Roolvink","year":"2014","journal-title":"American Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1067\/mhj.2002.126114","article-title":"Esmolol in acute ischaemic syndromes","volume":"144","author":"Mitchell","year":"2002","journal-title":"American Heart Journal"},{"issue":"5-6","key":"10.1002\/14651858.CD012484.pub2-BIB0034|cit34","first-page":"391","article-title":"Intravenous and oral practolol in the acute stages of myocardial infarction","volume":"7","author":"Evemy","year":"1978","journal-title":"European Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0002-8703(99)70405-9","article-title":"Effect of intravenous metoprolol before hospital admission on chest pain in suspected acute myocardial infarction","volume":"137","author":"Gardtman","year":"1999","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000174399","article-title":"Morbidity and quality of life 5 years after early intervention with metoprolol in suspected acute myocardial infarction","volume":"75","author":"Herlitz","year":"1988","journal-title":"Cardiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/hrt.51.5.539","article-title":"Development of congestive heart failure after treatment with metoprolol in acute myocardial infarction","volume":"51","author":"Herlitz","year":"1984","journal-title":"British Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.0954-6820.1988.tb15791.x","article-title":"Effects on mortality during five years after early intervention with metoprolol in suspected acute myocardial infarction","volume":"223","author":"Herlitz","year":"1988","journal-title":"Acta Medica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0167-5273(86)90010-0","article-title":"The influence of early intervention in acute myocardial infarction on long-term mortality and morbidity as assessed in the G\u00f6teborg metoprolol trial","volume":"10","author":"Herlitz","year":"Mar 1986","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000176529","article-title":"Ten-year mortality among patients with suspected acute myocardial infarction in relation to early diagnosis","volume":"84","author":"Herlitz","year":"1994","journal-title":"Cardiology"},{"issue":"8251","key":"10.1002\/14651858.CD012484.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0140-6736(81)91101-6","article-title":"Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial","volume":"2","author":"Hjalmarson","year":"1981","journal-title":"Lancet"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD012484.pub2-BIB0042|cit42","first-page":"26","article-title":"The G\u00f6teborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction","volume":"67","author":"Hjalmarson","year":"1983","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD012484.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198303173081102","article-title":"A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias","volume":"308","author":"Ryd\u00e9n","year":"1983","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1253\/circj.CJ-11-0947","article-title":"Randomized study on the efficacy and safety of landiolol, an ultra-short-acting beta1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"76","author":"Hanada","year":"2012","journal-title":"Circulation Journal"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.eurheartj.a062152","article-title":"Effect of labetalol on indices of myocardial necrosis in patients with suspected acute infarction","volume":"8","author":"Heber","year":"1987","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"14E","DOI":"10.1016\/S0002-9149(84)80306-9","article-title":"Reduction of infarct size by the early use of intravenous timolol in acute myocardial infarction","volume":"54","author":"The International Collaborative Study Group","year":"1984","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM198401053100103","article-title":"Reduction of infarct size with the early use of timolol in acute myocardial infarction","volume":"310","author":"The International Collaborative Study Group","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"8591","key":"10.1002\/14651858.CD012484.pub2-BIB0048|cit48","first-page":"921","article-title":"Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1","volume":"1","author":"ISIS-1 (first International Study of Infarct Survival) collaborative group","year":"1988","journal-title":"Lancet"},{"issue":"8498","key":"10.1002\/14651858.CD012484.pub2-BIB0049|cit49","first-page":"57","article-title":"Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1","volume":"2","author":"ISIS-1 (first International Study of Infarct Survival) collaborative group","year":"1986","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD012484.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"34F","DOI":"10.1016\/0002-9149(86)90886-6","article-title":"Effect of beta blockade on ventricular fibrillation- and ventricular tachycardia-induced circulatory arrest in acute myocardial infarction","volume":"57","author":"Johansson","year":"1986","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0167-5273(88)90107-6","article-title":"Early intervention with propranolol after acute myocardial infarction: serial left ventricular function determined by M-mode and cross-sectional echocardiography","volume":"21","author":"Kaul","year":"1988","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0052|cit52","first-page":"45","article-title":"Effects of beta blockers on the parameters of acute phase response and level of circulating immune complexes in myocardial infarct","volume":"6","author":"Korochkin","year":"1991","journal-title":"Sovetskaia Meditsina"},{"issue":"21","key":"10.1002\/14651858.CD012484.pub2-BIB0053|cit53","first-page":"988","article-title":"A trial of propranolol in myocardial infarction","volume":"98","author":"Ledwich","year":"1968","journal-title":"Canadian Medical Association Journal"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0054|cit54","first-page":"5","article-title":"Beta-blockade by sotalol in early myocardial infarction decreases ventricular arrhythmias without increasing left ventricular volume","volume":"74","author":"Lloyd","year":"1988","journal-title":"South African Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0167-5273(91)90380-8","article-title":"Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course","volume":"31","author":"Mcmurray","year":"1991","journal-title":"International Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ahj.2012.07.020","article-title":"Study design for the \u201ceffect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion\u201d (METOCARD-CNIC): A randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction","volume":"164","author":"Ibanez","year":"2012","journal-title":"American Heart Journal"},{"issue":"14","key":"10.1002\/14651858.CD012484.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","article-title":"Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annemergmed.2014.07.010","article-title":"Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior ST-segment elevation acute myocardial infarction: insights from the METOCARD-CNIC trial","volume":"65","author":"Mateos","year":"Mar 2015","journal-title":"Annals of Emergency Medicine"},{"issue":"22","key":"10.1002\/14651858.CD012484.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2014.03.014","article-title":"Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction)","volume":"63","author":"Pizarro","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ijcard.2016.11.214","article-title":"Nutritional preconditioning by marine omega-3 fatty acids in patients with ST-segment elevation myocardial infarction: A METOCARD-CNIC trial substudy.","volume":"228","author":"Sala-Vila","year":"Feb 2017","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ijcard.2015.09.117","article-title":"QRS distortion in pre-reperfusion electrocardiogram is a bedside predictor of large myocardium at risk and infarct size (a METOCARD-CNIC trial substudy).","volume":"202","author":"Valle-Caballero","year":"Jan 2016","journal-title":"International Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/clc.4960130406","article-title":"Prognosis during one year for patients with myocardial infarction in relation to the development of Q waves: experiences from the Miami trial","volume":"13","author":"Herlitz","year":"1990","journal-title":"Clinical Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2796.1990.tb00205.x","article-title":"Mortality and morbidity during one year of follow-up in suspected acute myocardial infarction in relation to early diagnosis: experiences from the MIAMI trial","volume":"228","author":"Herlitz","year":"1990","journal-title":"Journal of Internal Medicine"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD012484.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-8703(88)90515-7","article-title":"Plasma catecholamine levels in acute myocardial infarction: influence of beta-adrenergic blockade and relation to central hemodynamics","volume":"115","author":"Murray","year":"1988","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0167-5273(88)90287-2","article-title":"Does acute-phase beta-blockade reduce mortality in acute myocardial infarction by limiting infarct size?","volume":"20","author":"Murray","year":"1988","journal-title":"International Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0167-5273(87)90335-4","article-title":"Metoprolol in acute myocardial infarction reduces ventricular arrhythmias both in the early stage and after the acute event","volume":"15","author":"Rehnqvist","year":"1987","journal-title":"International Journal of Cardiology"},{"issue":"14","key":"10.1002\/14651858.CD012484.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"G35","DOI":"10.1016\/0002-9149(85)90695-2","article-title":"Arrhythmias","volume":"56","author":"The MIAMI Trial Research Group","year":"1985","journal-title":"American Journal of Cardiology"},{"issue":"14","key":"10.1002\/14651858.CD012484.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"G30","DOI":"10.1016\/0002-9149(85)90694-0","article-title":"Narcotic analgesics and other antianginal drugs","volume":"56","author":"The MIAMI Trial Research Group","year":"1985","journal-title":"American Journal of Cardiology"},{"issue":"14","key":"10.1002\/14651858.CD012484.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"G39","DOI":"10.1016\/0002-9149(85)90696-4","article-title":"Other clinical findings and tolerability","volume":"56","author":"The MIAMI Trial Research Group","year":"1985","journal-title":"American Journal of Cardiology"},{"issue":"14","key":"10.1002\/14651858.CD012484.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"G3","DOI":"10.1016\/0002-9149(85)90689-7","article-title":"Patients and methods","volume":"56","author":"The MIAMI Trial Research Group","year":"1985","journal-title":"The American Journal of Cardiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.eurheartj.a061845","article-title":"Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial","volume":"6","author":"The MIAMI trial research group","year":"1985","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0735-1097(89)90051-X","article-title":"The in-hospital development of cardiogenic shock after myocardial infarction: Incidence, predictors of occurrence, outcome and prognostic factors","volume":"14","author":"Hands","year":"1989","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD012484.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0002-9149(99)80628-6","article-title":"Effects of previous angina pectoris in patients with first acute myocardial infarction not receiving thrombolytics","volume":"75","author":"Kloner","year":"1995","journal-title":"American Journal of Cardiology"},{"issue":"15","key":"10.1002\/14651858.CD012484.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/0002-9149(86)90195-5","article-title":"Hyaluronidase therapy for acute myocardial infarction: Results of a randomized, blinded, multicenter trial","volume":"57","author":"MILIS Study Group","year":"1986","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0002-8703(89)90617-0","article-title":"Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size","volume":"117","author":"Pohjola-Sintonen","year":"1989","journal-title":"American Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJM198407263110403","article-title":"Effect of propranolol on myocardial-infarct size in a randomised blinded multicenter trial","volume":"311","author":"Roberts","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD012484.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"38F","DOI":"10.1016\/0002-9149(86)90887-8","article-title":"Propranolol in acute myocardial infarction: the MILIS experience","volume":"57","author":"Rude","year":"1986","journal-title":"American Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD012484.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/0002-9149(83)90508-8","article-title":"Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients","volume":"52","author":"Rude","year":"1983","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-8703(89)90660-1","article-title":"Pericarditis in acute myocardial infarction: Characterization and clinical significance","volume":"117","author":"Tofler","year":"1989","journal-title":"American Heart Journal"},{"issue":"13","key":"10.1002\/14651858.CD012484.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/0002-9149(88)90882-X","article-title":"Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patients","volume":"62","author":"Tofler","year":"1988","journal-title":"American Journal of Cardiology"},{"issue":"13","key":"10.1002\/14651858.CD012484.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/0002-9149(85)90954-3","article-title":"Electrocardiographic, enzymatic and scintigraphic criteria of acute myocardial infarction as determined from study of 726 patients (a MILIS study)","volume":"55","author":"Turi","year":"1985","journal-title":"American Journal of Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD012484.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0002-9149(86)90606-5","article-title":"Sudden death and its relation to QT-interval prolongation after acute myocardial infarction: Two-year follow-up","volume":"57","author":"Wheelan","year":"1986","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1172\/JCI109677","article-title":"Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man","volume":"65","author":"Mueller","year":"1980","journal-title":"Journal of Clinical Investigation"},{"issue":"7479","key":"10.1002\/14651858.CD012484.pub2-BIB0084|cit84","first-page":"1435","article-title":"Propranolol in acute myocardial infarction. A multicentre trial.","volume":"2","author":"Bath","year":"1966","journal-title":"Lancet"},{"issue":"21","key":"10.1002\/14651858.CD012484.pub2-BIB0085|cit85","first-page":"689","article-title":"Propranolol (Inderal) in acute myocardial infarct","volume":"129","author":"Nielsen","year":"1967","journal-title":"Ugeskrift for Laeger"},{"issue":"5602","key":"10.1002\/14651858.CD012484.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/bmj.2.5602.398","article-title":"Trial of propranolol in acute myocardial infarction","volume":"2","author":"Norris","year":"1968","journal-title":"BMJ"},{"issue":"8096","key":"10.1002\/14651858.CD012484.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(78)91628-8","article-title":"Protective effect of propranolol in threatened myocardial infarction","volume":"2","author":"Norris","year":"1978","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD012484.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/hrt.43.6.617","article-title":"Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts","volume":"43","author":"Norris","year":"1980","journal-title":"British Heart Journal"},{"issue":"8408","key":"10.1002\/14651858.CD012484.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(84)90651-2","article-title":"Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol","volume":"2","author":"Norris","year":"1984","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012484.pub2-BIB0091|cit90","first-page":"I57","article-title":"Beta blockade after myocardial infarction: The Norwegian propranolol study in high-risk patients","volume":"67","author":"Hansteen","year":"1983","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0092|cit91","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1111\/j.1365-2125.1982.tb02054.x","article-title":"The Norwegian propranolol trial in selected patients","volume":"14","author":"Hansteen","year":"1982","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0090|cit92","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmj.284.6310.155","article-title":"One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial","volume":"284","author":"Hansteen","year":"1982","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD012484.pub2-BIB0093|cit93","first-page":"704","article-title":"Failure of intravenous pindolol to reduce the haemodynamic determinants of myocardial oxygen demand or enzymatically determined infarct size in acute myocardial infarction","volume":"15","author":"Owensby","year":"1985","journal-title":"Australian & New Zealand Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012484.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.CIR.57.6.1091","article-title":"Reduction of enzyme levels by propranolol after acute myocardial infarction","volume":"57","author":"Peter","year":"1978","journal-title":"Circulation"},{"issue":"34","key":"10.1002\/14651858.CD012484.pub2-BIB0095|cit95","first-page":"1091","article-title":"Adrenergic beta-receptor blockage in the treatment of acute myocardial infarction","volume":"78","author":"Raeder","year":"1967","journal-title":"Nordisk Medicin"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0096|cit96","first-page":"459","article-title":"Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol","volume":"4","author":"Ramsdale","journal-title":"American Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0002-8703(88)90480-2","article-title":"Prophylaxis of post-myocardial infarction dysrhythmias by long-term timolol therapy","volume":"115","author":"Ranganathan","year":"1988","journal-title":"American Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0098|cit98","first-page":"115","article-title":"Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study","volume":"29","author":"Coletta","year":"1999","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0099|cit99","first-page":"444","article-title":"Changes on release of MB isoenzyme of creatine kinase by propranolol in acute myocardial infarction (author's transl)","volume":"10","author":"Rolli","year":"1980","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/hrt.49.3.229","article-title":"Effect of very early intervention with metoprolol on myocardial infarct size","volume":"49","author":"Boyle","year":"Mar 1983","journal-title":"British Heart Journal"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/oxfordjournals.eurheartj.a061844","article-title":"Very early intervention with metoprolol in suspected acute myocardial infarction","volume":"6","author":"Salathia","year":"1985","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2008.10.017","article-title":"Influence of atenolol on coronary artery spasm after acute myocardial infarction in a Japanese population","volume":"139","author":"Shirotani","year":"2010","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD012484.pub2-BIB0103|cit103","first-page":"19","article-title":"The use of esmolol in patients with myocardial infarction complicated with acute left ventricular failure","volume":"45","author":"Tereshchenko","year":"2005","journal-title":"Kardiologiia"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Progress in Cardiovascular Diseases"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/01.CIR.76.3.610","article-title":"Beneficial effects of timolol on infarct size and late ventricular tachycardia in patients with acute myocardial infarction","volume":"3","author":"Roqu\u00e9","year":"1987","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5694\/j.1326-5377.1981.tb100839.x","article-title":"Beta-blockade in acute myocardial infarction. Inability of relatively late administration to influence infarct size and arrhythmias","volume":"2","author":"Tonkin","year":"1981","journal-title":"Medical Journal of Australia"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0735-1097(93)90044-2","article-title":"Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy","volume":"22","author":"Werf","year":"1993","journal-title":"Journal of the American College of Cardiology"},{"issue":"34","key":"10.1002\/14651858.CD012484.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1055\/s-2008-1070113","article-title":"Effect of metoprolol on infarct size after acute myocardial infarction (a double-blind study) (author's transl)","volume":"107","author":"Essen","year":"1982","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0954-6820.1976.tb05882.x","article-title":"Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction","volume":"587","author":"Waagstein","year":"1976","journal-title":"Acta Medica Scandinavica. Supplementum."},{"issue":"6218","key":"10.1002\/14651858.CD012484.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.280.6218.885","article-title":"Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction","volume":"280","author":"Wilcox","year":"2980","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0111|cit111","first-page":"273","article-title":"Effects of betaxolol on heart rate in patients with a recent transmural myocardial infarction","volume":"42","author":"Yang","year":"1987","journal-title":"Acta Cardiologica"},{"issue":"6364","key":"10.1002\/14651858.CD012484.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/bmj.286.6364.506","article-title":"Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction","volume":"286","author":"Rossi","year":"1983","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.0954-6820.1981.tb03655.x","article-title":"Early intravenous atenolol treatment in suspected acute myocardial infarction","volume":"651","author":"Sleight","year":"1981","journal-title":"Acta Medica Scandinavica. Supplementum"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1111\/j.1365-2125.1982.tb02057.x","article-title":"Early intravenous beta-blockade in myocardial infarction","volume":"14","author":"Sleight","year":"1982","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"8189","key":"10.1002\/14651858.CD012484.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(80)90231-7","article-title":"Early intravenous atenolol treatment in suspected acute myocardial infarction","volume":"2","author":"Yusuf","year":"1980","journal-title":"Lancet"},{"issue":"6 PT 2","key":"10.1002\/14651858.CD012484.pub2-BIB0116|cit116","first-page":"I32","article-title":"Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction","volume":"67","author":"Yusuf","year":"1983","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0167-5273(89)90247-7","article-title":"Early treatment with intravenous metoprolol for suspected acute myocardial infarction: a phase IV United States trial. Phase IV Metoprolol in Myocardial Infarction Study Group","volume":"23","author":"Antman","year":"1989","journal-title":"International Journal of Cardiology"},{"issue":"18","key":"10.1002\/14651858.CD012484.pub2-BIB0118|cit118","first-page":"637","article-title":"Cardioselective beta receptor blockade in acute myocardial infarct with talinolol","volume":"36","author":"Assmann","year":"Sep 1981","journal-title":"Zeitschrift fur die Gesamte Innere Medizin und Ihre Grenzgebiete"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0002-9149(92)91297-H","article-title":"Effect of timolol on cardiopulmonary exercise performance in men after myocardial infarction","volume":"69","author":"Barvik","year":"1992","journal-title":"American Journal of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD012484.pub2-BIB0120|cit120","first-page":"477","article-title":"Metoprolol and atropine in acute myocardial infarction","volume":"73","author":"Boyle","year":"1980","journal-title":"Irish Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0167-5273(94)90030-2","article-title":"Effects of the administration of captopril, metoprolol and of the captopril-metoprolol combination as adjuvant therapy during thrombolysis in acute myocardial infarction","volume":"46","author":"Pasquale","year":"1994","journal-title":"International Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD012484.pub2-BIB0122|cit122","first-page":"683","article-title":"Metoprolol in acute myocardial infarction--clinical effect and tolerance","volume":"28","author":"Dluzniewski","year":"1985","journal-title":"Kardiologia Polska"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/17843286.1968.11716677","article-title":"The use of propranolol (inderal) in acute myocardial infarction","volume":"23","author":"Dotremont","year":"1968","journal-title":"Acta Clinica Belgica"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1536\/jhj.45.11","article-title":"Effects of a beta-blocker on ventricular late potentials in patients with acute-anterior myocardial infarction receiving successful thrombolytic therapy","volume":"45","author":"Evrengul","year":"2004","journal-title":"Japanese Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD012484.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/01.CIR.103.6.813","article-title":"Effects of early use of atenolol or captopril on infarct size and ventricular volume. A double-blind comparison in patients with anterior acute myocardial infarction","volume":"103","author":"Galcer\u00e1-Tom\u00e1s","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"18A","DOI":"10.1016\/0002-9149(87)90494-2","article-title":"Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine\/metoprolol Trial (HINT)","volume":"60","author":"Lubsen","year":"1987","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/oxfordjournals.eurheartj.a062036","article-title":"Intravenous acebutolol raises serum potassium in acute myocardial infarction","volume":"7","author":"Jardine","year":"1986","journal-title":"European Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD012484.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.amjcard.2004.01.006","article-title":"Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects","volume":"93","author":"The Japanese Beta Blockers and Calcium Antagonists Myocardial Infarction (JBCMI) Investigators*","year":"2004","journal-title":"American Journal of Cardiology"},{"issue":"1-2","key":"10.1002\/14651858.CD012484.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0954-6820.1980.tb09674.x","article-title":"A comparative study of cardioselective beta-blockade and diazepam in patients with acute myocardial infarction and tachycardia","volume":"207","author":"Johansson","year":"1980","journal-title":"Acta Medica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2796.1999.00415.x","article-title":"A comparison of metoprolol and morphine in the treatment of chest pain in patients with suspected acute myocardial infarction - the MEMO study","volume":"245","author":"Everts","year":"1999","journal-title":"Journal of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012484.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1253\/circj.CJ-10-1078","article-title":"Secondary preventive effects of a calcium antagonist for ischemic heart attack - randomized parallel comparison with \u03b2-blockers","volume":"75","author":"Nakagomi","year":"2011","journal-title":"Circulation Journal"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ijcard.2012.04.096","article-title":"Intracoronary followed by intravenous administration of the short-acting beta-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention","volume":"167","author":"Park","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/01.CIR.77.5.1081","article-title":"Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study inpatients with anterior myocardial infarction and single-vessel disease","volume":"77","author":"Pouleur","year":"1988","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1136\/bmj.i4801","article-title":"\u03b2 blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study","volume":"354","author":"Puymirat","year":"Sep 2016","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1540-8167.1992.tb01090.x","article-title":"Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions","volume":"3","author":"Schwartz","year":"1992","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/bmj.4.5578.508","article-title":"Beta-adrenergic blockade and cardiac arrhythmias","volume":"4","author":"Sloman","year":"1967","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0002-9149(66)90070-1","article-title":"Treatment of acute myocardial infarction with propranolol","volume":"18","author":"Snow","year":"1966","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0138|cit138","first-page":"14-7, AXV","article-title":"Effects of metoprolol on the signal averaged electrocardiogram and QT dispersion in acute myocardial infarction","volume":"2","author":"Tekten","year":"2002","journal-title":"Anadolu Kardiyoloji Dergisi"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0139|cit139","unstructured":"EUCTR2018-000590-75-NO BEta-Blocker Treatment after Acute Myocardial Infarction in revascularized patients with preserved left ventricular systolic function (BETAMI trial) http:\/\/apps.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2018-000590-75-NO (nov 2019)"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ahj.2018.10.005","article-title":"BEtablocker Treatment after Acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study","volume":"208","author":"Munkhaugen","year":"2019","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0141|cit141","unstructured":"NCT03646357 BEtablocker Treatment after Acute Myocardial Infarction in patients without reduced left ventricular systolic function (BETAMI) https:\/\/clinicaltrials.gov\/ct2\/show\/nct03646357"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0142|cit142","unstructured":"NCT03579914 Effect of intravenous metoprolol combining RIPC on myocardial protection in STEMI patients https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03579914"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0143|cit143","unstructured":"EUCTR2017-002336-17-SE Registry based randomised study of betablockers after myocardial infarction (REDUCE SWEDEHEART) http:\/\/apps.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2017-002336-17-SE"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0144|cit144","unstructured":"NCT03278509 Evaluation of decreased usage of betablockers after myocardial infarction in the SWEDEHEART registry (REDUCE-SWEDEHEART) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03278509"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1152\/ajplegacy.1948.153.3.586","article-title":"A study of the adrenotropic receptors","volume":"153","author":"Ahlquist","year":"1948","journal-title":"American Journal of Physiology"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1017\/S1481803500010137","article-title":"Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis","volume":"10","author":"Al-Reesi","year":"2008","journal-title":"Canadian Journal of Emergency Medicine"},{"issue":"7748","key":"10.1002\/14651858.CD012484.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","article-title":"Retire statistical significance.","volume":"567","author":"Amrhein","year":"March 2019","journal-title":"Springer Nature"},{"issue":"24","key":"10.1002\/14651858.CD012484.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"9654","key":"10.1002\/14651858.CD012484.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(08)61560-3","article-title":"Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis","volume":"372","author":"Bangalore","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD012484.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with beta-blockers for myocardial infarction: a meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"American Journal of Medicine"},{"issue":"7342","key":"10.1002\/14651858.CD012484.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(64)91275-9","article-title":"A new adrenergic beta receptor antagonist","volume":"1","author":"Black","year":"1964","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1553-2712.2009.00625.x","article-title":"Does the early administration of beta-blockers improve the in-hospital mortality rate of patients admitted with acute coronary syndrome?","volume":"17","author":"Brandler","year":"2010","journal-title":"Academic Emergency Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012484.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/hrt.2008.153387","article-title":"Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events","volume":"95","author":"Brieger","year":"2009","journal-title":"Heart (British Cardiac Society)"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/circ.54.3.947585","article-title":"Letter: Grading of angina pectoris","volume":"54","author":"Campeau","year":"1976","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 Statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijcard.2012.10.050","article-title":"Early intravenous beta-blockers in patients with acute coronary syndrome - a meta-analysis of randomized trials","volume":"168","author":"Chatterjee","year":"2013","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"f55","DOI":"10.1136\/bmj.f55","article-title":"Benefits of beta blockers in patients with heart failure and reduced ejection fraction: network meta-analysis","volume":"346","author":"Chatterjee","year":"2013","journal-title":"BMJ"},{"issue":"9497","key":"10.1002\/14651858.CD012484.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"issue":"7470","key":"10.1002\/14651858.CD012484.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0140-6736(66)90533-2","article-title":"Absence of prophylactic effect of propranolol in myocardial infarction","volume":"2","author":"Clausen","year":"1966","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0160|cit160","doi-asserted-by":"crossref","unstructured":"Cooper R Cutler J Desvigne-Nickens P Fortmann SP Friedman L Havlik R Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention Circulation 2000 3137 47","DOI":"10.1161\/01.CIR.102.25.3137"},{"issue":"12","key":"10.1002\/14651858.CD012484.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/pds.1844","article-title":"Systematic reviews of adverse effects of drug interventions: a survey of their conduct and reporting quality","volume":"18","author":"Cornelius","year":"2009","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ehjcvp\/pvy034","article-title":"Effect of oral \u03b2-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis","volume":"5","author":"Dahl Aarvik","year":"2019","journal-title":"European Heart Journal. Cardiovascular Pharmacotherapy"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0163|cit163","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017) Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"9627","key":"10.1002\/14651858.CD012484.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial","volume":"371","author":"Devereaux","year":"2008","journal-title":"Lancet"},{"issue":"7109","key":"10.1002\/14651858.CD012484.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijcard.2016.08.293","article-title":"Intravenous beta-blockers for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials","volume":"223","author":"Elgendy","year":"2016","journal-title":"International Journal of Cardiology"},{"issue":"7200","key":"10.1002\/14651858.CD012484.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(86)80250-9","article-title":"Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia","volume":"7","author":"Friedman","year":"1986","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD012484.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwj069","article-title":"Bias in clinical intervention research","volume":"163","author":"Gluud","year":"2006","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0173|cit173","volume-title":"Principles of Pharmacology - The Pathophysiologic Basis of Drug Therapy","author":"Golan","year":"2011"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2165\/00003495-197407010-00008","article-title":"Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston Collaborative Drug Surveillance Program","volume":"7","author":"Greenblatt","year":"1974","journal-title":"Drugs"},{"issue":"7650","key":"10.1002\/14651858.CD012484.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"20","key":"10.1002\/14651858.CD012484.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0178|cit178","doi-asserted-by":"crossref","unstructured":"Heneghan C Goldacre B Mahtani KR Why clinical trial outcomes fail to translate into benefits for patients Trials 2017 122","DOI":"10.1186\/s13063-017-1870-2"},{"issue":"11","key":"10.1002\/14651858.CD012484.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD012484.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0181|cit181","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"9","key":"10.1002\/14651858.CD012484.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/sim.4088","article-title":"Sequential methods for random-effects meta-analysis","volume":"30","author":"Higgins","year":"2011","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0183|cit183","unstructured":"Higgins JP Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors) Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0184|cit184","first-page":"204887261983060","article-title":"Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials","volume":"Epub ahead of p","author":"Hoedemaker","year":"2019","journal-title":"European Heart Journal. Acute Cardiovascular Care"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD012484.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-8703(81)90317-3","article-title":"Abrupt cessation of treatment in hypertension: consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome","volume":"102","author":"Houston","year":"1981","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"e1119","DOI":"10.1136\/bmj.e1119","article-title":"Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors","volume":"344","author":"Hrobjartsson","year":"2012","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1503\/cmaj.120744","article-title":"Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors","volume":"185","author":"Hrobjartsson","year":"2013","journal-title":"Canadian Medical Association Journal"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/ije\/dyt270","article-title":"Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors","volume":"43","author":"Hrobjartsson","year":"2014","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ije\/dyu115","article-title":"Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and non-blind sub-studies","volume":"43","author":"Hrobjartsson","year":"2014","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0190|cit190","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) adopts Consolidated Guideline on Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use International Digest of Health Legislation 1997 231 4"},{"issue":"19","key":"10.1002\/14651858.CD012484.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archinternmed.2009.313","article-title":"Adverse events in randomized trials: neglected, restricted, distorted, and silenced","volume":"169","author":"Ioannidis","year":"2009","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0193|cit193","doi-asserted-by":"publisher","first-page":"Ed000111","DOI":"10.1002\/14651858.ED000111","article-title":"Viewpoint: taking into account risks of random errors when analysing multiple outcomes in systematic reviews","volume":"3","author":"Jakobsen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7556","key":"10.1002\/14651858.CD012484.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1136\/bmj.332.7556.1482","article-title":"Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial","volume":"332","author":"Juul","year":"2006","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD012484.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.288.3.351","article-title":"Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction","volume":"288","author":"Ko","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0197|cit197","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1111\/j.1365-2125.1982.tb02055.x","article-title":"Beta-blockade after myocardial infarction - a statistical view","volume":"14 Suppl 1","author":"Lewis","year":"1982","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD012484.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192666","article-title":"Executive summary: heart disease and stroke statistics - 2010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"issue":"15","key":"10.1002\/14651858.CD012484.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","article-title":"Expert consensus document on beta-adrenergic receptor blockers","volume":"25","author":"Lopez-Sendon","year":"2004","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0201|cit201","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"28","key":"10.1002\/14651858.CD012484.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2125.1975.tb01570.x","article-title":"An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man","volume":"2","author":"Marlin","year":"1975","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1074248415608011","article-title":"Does oral beta-blocker therapy improve long-term survival in ST-segment elevation myocardial infarction with preserved systolic function? A meta-analysis","volume":"21","author":"Misumida","year":"2016","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"9128","key":"10.1002\/14651858.CD012484.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD012484.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"38","key":"10.1002\/14651858.CD012484.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"European Heart Journal"},{"issue":"42","key":"10.1002\/14651858.CD012484.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1093\/eurheartj\/ehu299","article-title":"Cardiovascular disease in Europe 2014: epidemiological update","volume":"35","author":"Nichols","year":"2014","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"i2013 ACCF\/AHA guideline for the management of ST-elevation myocardial Infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD012484.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.amjmed.2004.04.026","article-title":"Availability of large-scale evidence on specific harms from systematic reviews of randomized trials","volume":"117","author":"Papanikolaou","year":"2004","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0211|cit211","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006743.pub2","article-title":"Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event","author":"Perez","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0002-8703(89)90617-0","article-title":"Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size","volume":"117","author":"Pohjola-Sintonen","year":"1989","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S0025727300009455","article-title":"Putting theory into practice: James Black, receptor theory and the development of the beta-blockers at ICI, 1958-1978","volume":"50","author":"Quirke","year":"2006","journal-title":"Medical History"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0214|cit214","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"3","key":"10.1002\/14651858.CD012484.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0216|cit216","first-page":"e25","article-title":"Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/sim.2971","article-title":"Arcsine test for publication bias in meta-analyses with binary outcomes","volume":"27","author":"R\u00fccker","year":"2008","journal-title":"Statistics in Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012484.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovic","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"35","key":"10.1002\/14651858.CD012484.pub2-BIB0220|cit220","first-page":"1","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovic","year":"2012","journal-title":"Health Technology Assesment"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between Risk-of-Bias assessments and results of randomized trials in Cochrane Reviews: the ROBES meta-epidemiologic study","volume":"187","author":"Savovic","year":"2018","journal-title":"American jJournal of Epidemiology"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1136\/bmj.e356","article-title":"25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study","volume":"344","author":"Schmidt","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD012484.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012484.pub2-BIB0225|cit225","first-page":"677","article-title":"Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations","volume":"169","author":"Sch\u00fcnemann","year":"2003","journal-title":"CMAJ: Canadian Medical Association journal"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0226|cit226","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A editor(s) Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0227|cit227","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2999(75)90227-7","article-title":"A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta-adrenoceptors","volume":"34","author":"Singh","year":"1975","journal-title":"European Journal of Pharmacology"},{"issue":"20","key":"10.1002\/14651858.CD012484.pub2-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD012484.pub2-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/0002-8703(89)90007-0","article-title":"The spectrum of death after myocardial infarction: a necropsy study","volume":"118","author":"Stevenson","year":"1989","journal-title":"American Heart Journal"},{"issue":"11","key":"10.1002\/14651858.CD012484.pub2-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJM198203183061102","article-title":"Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?","volume":"306","author":"Taylor","year":"1982","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012484.pub2-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1525-1497.2005.00269.x","article-title":"Prevalence of depression in survivors of acute myocardial infarction","volume":"21","author":"Thombs","year":"2006","journal-title":"Journal of General Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012484.pub2-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.gheart.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"7","author":"Thygesen","year":"2012","journal-title":"Global Heart"},{"issue":"2","key":"10.1002\/14651858.CD012484.pub2-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1037\/0022-006X.62.2.350","article-title":"Social phobia: a comparison of behavior therapy and atenolol","volume":"62","author":"Turner","year":"1994","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"5543","key":"10.1002\/14651858.CD012484.pub2-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/bmj.2.5543.50","article-title":"Propranolol-induced depression","volume":"2","author":"Waal","year":"1967","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD012484.pub2-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0238|cit238","doi-asserted-by":"crossref","unstructured":"Warren SC Warren SG Propranolol and sexual impotence Annals of Internal Medicine 1977 112","DOI":"10.7326\/0003-4819-86-1-112_1"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0239|cit239","unstructured":"World Health Organization (WHO) Cardiovascular Disease www.who.int\/cardiovascular_diseases\/en\/ (accessed before 5 December 2016)"},{"issue":"11","key":"10.1002\/14651858.CD012484.pub2-BIB0240|cit240","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002003.pub4","article-title":"Beta-blockers for hypertension","author":"Wiysonge","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7644","key":"10.1002\/14651858.CD012484.pub2-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0242|cit242","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD012484.pub2-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Progress in Cardiovascular Diseases"},{"key":"10.1002\/14651858.CD012484.pub2-BIB0244|cit244","first-page":"f7668","article-title":"Quality of reporting in systematic reviews of adverse events: systematic review","volume":"348","author":"Zorzela","year":"2014","journal-title":"BMJ (Clinical research ed.)"},{"issue":"12","key":"10.1002\/14651858.CD012484.pub2-BIB0245|cit245","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012484","article-title":"Beta-blockers for suspected or diagnosed acute myocardial infarction","author":"Nielsen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012484.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T19:12:17Z","timestamp":1722193937000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012484.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,17]]},"references-count":245,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012484.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,17]]}}}